FDA approves new treatment to prevent or reduce frequency of bleeding episodes in patients with hemophilia A who have Factor VIII inhibitors.
Category Archives: Food Safety News
Giant/Martin’s Alerts Customers to Voluntary Recall of Store Brand Frozen Whole Kernel Sweet Corn
GIANT Food Stores, LLC and MARTIN’S Food Markets announced it removed from sale GIANT/MARTIN’S Brand Frozen Whole Kernel Sweet Corn due to potential Listeria monocytogenes contamination.
Read The Complete Story!
Giant Food Alerts Customers to Voluntary Recall of Store Brand Frozen Whole Kernel Sweet Corn
Giant Food, LLC announced it removed from sale Giant Brand Frozen Whole Kernel Sweet Corn due to potential Listeria monocytogenes contamination.
Read The Complete Story!
Stop & Shop Alerts Customers to Voluntary Recall of Store Brand Frozen Whole Kernel Sweet Corn
The Stop & Shop Supermarket Company LLC announced it removed from sale Stop & Shop Brand Frozen Whole Kernel Sweet Corn due to potential Listeria monocytogenes contamination.
Read The Complete Story!
Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA’s comprehensive new policy approach to facilitating the development of innovative regenerative medicine products to improve human health
Commissioner statement on FDA’s comprehensive regenerative medicine policy framework to spur innovation, efficient access to potentially transformative products, while ensuring safety and efficacy
FDA announces comprehensive regenerative medicine policy framework
FDA announces comprehensive regenerative medicine policy framework to spur innovation, efficient access to potentially transformative products, while ensuring safety and efficacy.
FDA unveils a streamlined path for the authorization of tumor profiling tests alongside its latest product action
Newly authorized test detects genetic cancer mutations in 468 unique genes
FDA approves treatment for rare genetic enzyme disorder
FDA approves treatment for rare genetic enzyme disorder
FDA grants marketing authorization of the first device for use in helping to reduce the symptoms of opioid withdrawal
FDA permits marketing of the first device for use in helping to reduce the symptoms of opioid withdrawal
Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA advisory about deadly risks associated with kratom
A botanical substance known as kratom has raised significant concerns given its increasing prevalence and potential safety risks. The FDA has issued a public health advisory related to mounting concerns regarding risks associated with the use of kratom.